Abingworth LLP current holdings: USA Other Stocks
Abingworth LLP reported $0.10 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 16 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are Sientra, Proteon, Paratek.
- Sientra: Country of operation —; Class Common; Shares 2,199,012; Value $19,769,000.
- Proteon: Country of operation —; Class Common; Shares 2,017,872; Value $18,383,000.
- Paratek: Country of operation United States; Class Common; Shares 1,301,413; Value $16,918,000.
- Cempra: Country of operation —; Class Common; Shares 383,935; Value $9,287,000.
Form 13F-HR as filed (SEC CIK 1397144): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
Sientra
CUSIP 82621J105 | | Common | 2,199,012 | $19,769,000 | 2016-09-30 | 2016-11-14 |
|---|
Proteon
CUSIP 74371L109 | | Common | 2,017,872 | $18,383,000 | 2016-09-30 | 2016-11-14 |
|---|
Paratek
CUSIP 699374302 | United States | Common | 1,301,413 | $16,918,000 | 2016-09-30 | 2016-11-14 |
|---|
Cempra
CUSIP 15130J109 | | Common | 383,935 | $9,287,000 | 2016-09-30 | 2016-11-14 |
|---|
Chiasma
CUSIP 16706W102 | | Common | 2,080,595 | $6,096,000 | 2016-09-30 | 2016-11-14 |
|---|
Dicerna
CUSIP 253031108 | | Common | 945,757 | $5,561,000 | 2016-09-30 | 2016-11-14 |
|---|
Novan
CUSIP 66988N106 | | Common | 200,000 | $4,032,000 | 2016-09-30 | 2016-11-14 |
|---|
Lombard Medical
CUSIP G55598109 | | Common | 3,473,452 | $3,201,000 | 2016-09-30 | 2016-11-14 |
|---|
Cymabay
CUSIP 23257D103 | United States | Common | 1,600,000 | $3,104,000 | 2016-09-30 | 2016-11-14 |
|---|
Dermira
CUSIP 24983L104 | | Common | 70,000 | $2,367,000 | 2016-09-30 | 2016-11-14 |
|---|
Senseonics
CUSIP 81727U105 | United States | Common | 516,882 | $2,000,000 | 2016-09-30 | 2016-11-14 |
|---|
Aurinia Pharma
CUSIP 03674U201 | | Common | 512,036 | $1,531,000 | 2016-09-30 | 2016-11-14 |
|---|
Immune Design
CUSIP 45252L103 | | Common | 197,300 | $1,494,000 | 2016-09-30 | 2016-11-14 |
|---|
Regulus
CUSIP 75915K101 | | Common | 327,350 | $1,080,000 | 2016-09-30 | 2016-11-14 |
|---|
Histogenix
CUSIP 43358V109 | | Common | 176,904 | $543,000 | 2016-09-30 | 2016-11-14 |
|---|
Oncogenex Pharma
CUSIP 68230A106 | | Common | 396,104 | $195,000 | 2016-09-30 | 2016-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |